Article info

Download PDFPDF

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)

Authors

  • Angelika M. Starzer Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, AustriaComprehensive Cancer Center, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Anna S. Berghoff Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, AustriaComprehensive Cancer Center, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Anna S. Berghoff; anna.berghoff{at}meduniwien.ac.at
View Full Text

Citation

Starzer AM, Berghoff AS
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)

Publication history

  • Received October 29, 2019
  • Revised February 2, 2020
  • Accepted February 5, 2020
  • First published March 9, 2020.
Online issue publication 
March 09, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.